AI holds promise for faster diagnosis but needs rigorous validation, experts warn

Experts participating in a healthcare sustainability forum have highlighted the dual potential and risks of deploying artificial intelligence in clinical settings across South Asia. While acknowledging AI's capacity to enable faster and more cost-effective diagnoses, panelists stressed that regulatory oversight and rigorous validation protocols must precede large-scale implementation in hospitals and diagnostic centers.

The discussion underscored growing recognition that AI-driven healthcare tools could democratize access to quality diagnostics, particularly in resource-constrained regions. However, experts cautioned that algorithmic bias, data accuracy, and the need for clinician oversight remain critical challenges that must be addressed before AI systems can be reliably integrated into patient care pathways.

Data security emerged as a primary concern among participants, who emphasized the need for stringent safeguards to protect patient information and ensure compliance with emerging regulatory frameworks. The experts also called for transparent protocols governing how AI systems are trained, validated, and monitored in clinical practice to maintain public trust and ensure equitable outcomes across diverse populations.

The dialogue reflected broader global conversations about balancing innovation with ethical responsibility in healthcare transformation, particularly as developing nations seek to leverage technology for improving medical accessibility and outcomes while maintaining robust governance standards.